| __timestamp | MorphoSys AG | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9689000 | 5496000 |
| Thursday, January 1, 2015 | 10431000 | 9786000 |
| Friday, January 1, 2016 | 9618000 | 6792000 |
| Sunday, January 1, 2017 | 12348000 | 7313000 |
| Monday, January 1, 2018 | 28310241 | 8382000 |
| Tuesday, January 1, 2019 | 59336147 | 10803000 |
| Wednesday, January 1, 2020 | 159145941 | 12944000 |
| Friday, January 1, 2021 | 199800000 | 21967000 |
| Saturday, January 1, 2022 | 90225000 | 32810000 |
| Sunday, January 1, 2023 | 92538000 | 46542000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, understanding financial trends is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Xenon Pharmaceuticals Inc. and MorphoSys AG from 2014 to 2023. Over this period, MorphoSys AG's SG&A expenses surged by approximately 855%, peaking in 2021, while Xenon Pharmaceuticals Inc. saw a more modest increase of around 747%, with a notable rise in 2023. This trend highlights MorphoSys AG's aggressive expansion strategy, particularly between 2019 and 2021, where expenses nearly tripled. In contrast, Xenon Pharmaceuticals Inc. maintained a steadier growth trajectory, reflecting a more conservative approach. These insights provide a window into the strategic priorities of these companies, offering investors and industry analysts a deeper understanding of their operational focus and market positioning.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or MorphoSys AG
SG&A Efficiency Analysis: Comparing Insmed Incorporated and MorphoSys AG
Ascendis Pharma A/S or Xenon Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Blueprint Medicines Corporation or Xenon Pharmaceuticals Inc.
Comparing SG&A Expenses: Pharming Group N.V. vs Xenon Pharmaceuticals Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Grifols, S.A. and MorphoSys AG
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs MorphoSys AG Trends and Insights
Alkermes plc and MorphoSys AG: SG&A Spending Patterns Compared
ADMA Biologics, Inc. and Xenon Pharmaceuticals Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of MorphoSys AG and Amicus Therapeutics, Inc.
Breaking Down SG&A Expenses: MorphoSys AG vs Arrowhead Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? MorphoSys AG or Taro Pharmaceutical Industries Ltd.